SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-21-064526
Filing Date
2021-05-11
Accepted
2021-05-11 16:08:02
Documents
71
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q tm2111690d1_10q.htm 10-Q 436206
2 EXHIBIT 31.1 tm2111690d1_ex31-1.htm EX-31.1 7960
3 EXHIBIT 31.2 tm2111690d1_ex31-2.htm EX-31.2 8074
4 EXHIBIT 32.1 tm2111690d1_ex32-1.htm EX-32.1 3767
5 EXHIBIT 32.2 tm2111690d1_ex32-2.htm EX-32.2 3785
  Complete submission text file 0001104659-21-064526.txt   4327188

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ards-20210331.xml EX-101.INS 878433
7 XBRL TAXONOMY EXTENSION SCHEMA ards-20210331.xsd EX-101.SCH 50600
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ards-20210331_cal.xml EX-101.CAL 45207
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ards-20210331_def.xml EX-101.DEF 152643
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ards-20210331_lab.xml EX-101.LAB 426652
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ards-20210331_pre.xml EX-101.PRE 327309
Mailing Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032
Business Address 983 UNIVERSITY AVENUE, BLDG. B LOS GATOS CA 95032 (408) 385-1742
Aridis Pharmaceuticals, Inc. (Filer) CIK: 0001614067 (see all company filings)

IRS No.: 320074500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38630 | Film No.: 21911323
SIC: 2834 Pharmaceutical Preparations